Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...
News Medical on MSN12d
Potential Keys to Cell Therapy Response for Leukemia IdentifiedDana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...
200 Join ABMDR for Chance to save Lives of Sahag-Mesrob Principal Maral Boyadjian and Other Patients
In recent days, the Armenian Bone Marrow Donor Registry held two donor recruitment drives in the Los Angeles area, to find ...
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...
Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
Why Children With Down Syndrome Have Higher Risk of Leukemia Sep. 26 ... made a world first breakthrough into creating blood stem cells that closely resemble those in the human body.
Raymond Cheslock, a father of two, was diagnosed with leukemia in 2019. After undergoing a round of chemotherapy at a ...
A record number of Dutch residents donated stem cells last year to help patients with leukemia and other life-threatening ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results